BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 17304785)

  • 1. Current literature questions the routine use of low-dose dopamine.
    Abay MC; Reyes JD; Everts K; Wisser J
    AANA J; 2007 Feb; 75(1):57-63. PubMed ID: 17304785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of fenoldopam mesylate in critically ill patients at risk for acute renal failure is dose dependent.
    Samuels J; Finkel K; Gubert M; Johnson T; Shaw A
    Ren Fail; 2005; 27(1):101-5. PubMed ID: 15717642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute renal failure after liver transplantation: the role of dopamine and fenoldopam.
    Leung N; Textor SC
    Liver Transpl; 2004 Aug; 10(8):993-4. PubMed ID: 15390324
    [No Abstract]   [Full Text] [Related]  

  • 4. Fenoldopam: renal-dose dopamine redux?
    Murray PT
    Crit Care Med; 2006 Mar; 34(3):910-1. PubMed ID: 16505681
    [No Abstract]   [Full Text] [Related]  

  • 5. Dopamine and dopamine receptor agonists in cardiovascular therapy.
    Murphy MB; Elliott WJ
    Crit Care Med; 1990 Jan; 18(1 Pt 2):S14-8. PubMed ID: 1967161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal-dose (low-dose) dopamine for the treatment of sepsis-related and other forms of acute renal failure: ineffective and probably dangerous.
    Power DA; Duggan J; Brady HR
    Clin Exp Pharmacol Physiol Suppl; 1999 Apr; 26():S23-8. PubMed ID: 10386250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine "renal dose" versus fenoldopam mesylate to prevent ischemia-reperfusion injury in renal transplantation.
    Fontana I; Germi MR; Beatini M; Fontana S; Bertocchi M; Porcile E; Saltalamacchia L; Ornis S; Ghinolfi D; Bonifazio L; Valente U
    Transplant Proc; 2005; 37(6):2474-5. PubMed ID: 16182714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fenoldopam vs dopamine as a nephroprotective strategy during living donor kidney transplantation: preliminary data.
    Sorbello M; Morello G; Paratore A; Cutuli M; Mistretta G; Belluoccio AA; Veroux M; Veroux P; Macarone M; Gagliano M; Mangianeli S
    Transplant Proc; 2007; 39(6):1794-6. PubMed ID: 17692615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Renal-protective dose of dopamine: myth or reality?].
    de Werra P; Bracco D
    Rev Med Suisse Romande; 1999 Mar; 119(3):203-8. PubMed ID: 10218415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diuretics and dopamine for the prevention and treatment of acute renal failure: a critical reappraisal.
    Gambaro G; Bertaglia G; Puma G; D'Angelo A
    J Nephrol; 2002; 15(3):213-9. PubMed ID: 12113589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal-dose dopamine: from hypothesis to paradigm to dogma to myth and, finally, superstition?
    Jones D; Bellomo R
    J Intensive Care Med; 2005; 20(4):199-211. PubMed ID: 16061903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of dopamine in acute renal failure.
    Harper L; Savage CO
    Clin Nephrol; 1997 May; 47(5):347-9. PubMed ID: 9181285
    [No Abstract]   [Full Text] [Related]  

  • 13. Renal dose dopamine--it's myth and the truth.
    Padmanabhan R
    J Assoc Physicians India; 2002 Apr; 50():571-5. PubMed ID: 12164413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of fenoldopam with dopamine and sodium nitroprusside in patients undergoing cross-clamping of the abdominal aorta.
    Oliver WC; Nuttall GA; Cherry KJ; Decker PA; Bower T; Ereth MH
    Anesth Analg; 2006 Oct; 103(4):833-40. PubMed ID: 17000789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Fenoldopam and kidney function in a case of abdominal aortic pseudoaneurysm with supra-renal clamping in an emergency protocol].
    Caporelli S; Loggi S; Zompanti V; Romano R; Carbonari L; Alò F; Antognini M; Pelaia P
    Recenti Prog Med; 2003 Nov; 94(11):501-5. PubMed ID: 14679918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential of dopamine A-1 agonists in the management of acute renal failure.
    Singer I; Epstein M
    Am J Kidney Dis; 1998 May; 31(5):743-55. PubMed ID: 9590183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical use of dopamine receptor agonists.
    Murphy MB
    Proc West Pharmacol Soc; 1990; 33():31-5. PubMed ID: 1980363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose dopamine: a physiologically based review.
    Schenarts PJ; Sagraves SG; Bard MR; Toschlog EA; Goettler CE; Newell MA; Rotondo MF
    Curr Surg; 2006; 63(3):219-25. PubMed ID: 16757377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Is preventive perioperative dopamine administration of value?].
    Bund M; Seitz W; Kirchner E
    Anaesthesiol Reanim; 1995; 20(3):76-81. PubMed ID: 8526963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Is dopamine in acute renal failure a treatment of the past?].
    Hahn R
    Lakartidningen; 2002 Mar; 99(13):1430-1. PubMed ID: 11989349
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.